Chapter 166 Pulmonary Thromboembolism

  1. Alwood AJ et al: Anticoagulant effects of low-molecular-weight heparins in healthy cats, J Vet Intern Med 21:378, 2007. PUBMED Abstract
  2. Breuhl EL et al: A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated haemolytic anemia, J Am Anim Hosp Assoc 45:125, 2009. PUBMED Abstract
  3. Hirsh J, Raschke R: Heparin and low-molecular-weight-heparin: the seventh AACCP conference on antithrombotic and thrombolytic therapy, Chest 126:188S, 2004. PUBMED Abstract
  4. Hogan DF et al: Antiplatelet effects and pharmacodynamics of clopidogrel in cats, J Am Vet Med Assoc 225:1406, 2004. PUBMED Abstract
  5. Hoh CM et al: Evaluation of the effect of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs, Am J Vet Res 72:1038, 2011. PUBMED Abstract
  6. Hyers TM et al: Antithrombotic therapy for venous thromboembolic disease (sixth ACCP consensus conference on antithrombotic therapy), Chest 119:176S, 2001.
  7. Johnson LR et al: Pulmonary thromboembolism in 29 dogs: 1985-1995, J Vet Intern Med 13:338, 1999. PUBMED Abstract
  8. LaRue MJ et al: Pulmonary thromboembolism in dogs: 47 cases (1986-1987), J Am Vet Med Assoc 197:1368, 1990.
  9. Lunsford KV et al: Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs, J Am Anim Hosp Assoc 45:261, 2009.
  10. Mellett AM, Nakamura RK, Bianco D: A prospective study of clopidogrel therapy in dogs with primary immune-mediated thrombocytopenia, J Vet Intern Med 25:71, 2011. PUBMED Abstract
  11. Mischke R et al: Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs, Am J Vet Res 62:595, 2001. PUBMED Abstract
  12. Norris CR et al: Pulmonary thromboembolism in cats: 29 cases (1987-1997), J Am Vet Med Assoc 215:1650, 1999. PUBMED Abstract
  13. Orcutt ES et al: Comparison of individually monitored unfractionated heparin versus low-dose aspirin on survival of dogs with immune-mediated hemolytic anemia, J Vet Intern Med 23:692, 2009 (abstract).
  14. Pittman JR, Koenig A, Brainard BM: The effect of unfractionated heparin on thromboelastographic analysis in healthy dogs, J Vet Emerg Crit Care 20:216, 2010. PUBMED Abstract
  15. Smith SA et al: Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term management with low dose aspirin in 24 cats, J Vet Intern Med 17:73, 2003. PUBMED Abstract
  16. Thompson MF, Scott-Montcrief JC, Hogan DF: Thrombolytic therapy in dogs and cats, J Vet Emerg Crit Care 11:111, 2001.
  17. Van De Wiele CM et al: Antithrombotic effect of enoxaparin in clinically healthy cats: a venous stasis model, J Vet Intern Med 24:185, 2010. PUBMED Abstract
  18. Wagg CR et al: Thromboelastography of dogs admitted to an intensive care unit, Vet Clin Pathol 28:453, 2009. PUBMED Abstract
  19. Weinkle TK et al: Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002), J Am Vet Med Assoc 26:1869, 2005. PUBMED Abstract